Market cap of CVS Health Corporation [CVS] reaches 124.72B – now what?

Related

CVS Health Corporation [NYSE: CVS] slipped around -0.17 points on Wednesday, while shares priced at $97.99 at the close of the session, down -0.17%. The company report on May 9, 2022 that KOIOS™ Nootropic Functional Beverages Launching in Over 600 CVS Locations.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

Koios is pleased to announce that its KOIOS™ nootropic functional beverages have been approved for placement in over 600 CVS locations. CVS is the largest retail pharmacy chain in the United States and one of the largest corporations in the world.

Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) is pleased to announce that its KOIOS™ nootropic functional beverages have been approved for placement and are now available in over 600 CVS locations in Texas, Tennessee, Missouri, New Jersey, California, Florida, Indiana and New York.

CVS Health Corporation stock is now -5.01% down from its year-to-date (YTD) trading value. CVS Stock saw the intraday high of $99.87 and lowest of $97.88 per share. The company’s 52-week high price is 111.25, which means current price is +3.13% above from all time high which was touched on 02/08/22.

Compared to the average trading volume of 5.73M shares, CVS reached a trading volume of 4638838 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about CVS Health Corporation [CVS]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $117.42 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Deutsche Bank have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Hold, with their previous recommendation back on March 29, 2022. The new note on the price target was released on February 11, 2022, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $121, while Goldman analysts kept a Buy rating on CVS stock.

The Average True Range (ATR) for CVS Health Corporation is set at 2.81, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.42. The Price to Book ratio for the last quarter was 1.74, with the Price to Cash per share for the same quarter was set at 8.91. Price to Free Cash Flow for CVS in the course of the last twelve months was 8.59 with Quick ratio for the last quarter at 0.60.

How has CVS stock performed recently?

CVS Health Corporation [CVS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.57. With this latest performance, CVS shares dropped by -6.18% in over the last four-week period, additionally plugging by 5.64% over the last 6 months – not to mention a rise of 17.52% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 42.66, with the RSI for the last a single of trading hit 42.39, and the three-weeks RSI is set at 43.46 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 103.21, while it was recorded at 98.69 for the last single week of trading, and 95.75 for the last 200 days.

CVS Health Corporation [CVS]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.12 and a Gross Margin at +17.77. CVS Health Corporation’s Net Margin is presently recorded at +2.71.

Return on Equity for this stock inclined to 10.95, with Return on Assets sitting at 3.30.

CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.90.

Earnings analysis for CVS Health Corporation [CVS]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 5.74%.

Insider trade positions for CVS Health Corporation [CVS]

There are presently around $101,505 million, or 79.90% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 109,236,922, which is approximately 0.812% of the company’s market cap and around 0.20% of the total institutional ownership; BLACKROCK INC., holding 93,556,501 shares of the stock with an approximate value of $9.18 billion in CVS stocks shares; and STATE STREET CORP, currently with $5.58 billion in CVS stock with ownership of nearly 2.824% of the company’s market capitalization.

Positions in CVS Health Corporation stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 1,108 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 53,173,245 shares. Additionally, 1,118 investors decreased positions by around 42,538,860 shares, while 224 investors held positions by with 938,362,491 shares. The mentioned changes placed institutional holdings at 1,034,074,596 shares, according to the latest SEC report filing. CVS stock had 226 new institutional investments in for a total of 7,386,839 shares, while 110 institutional investors sold positions of 2,563,386 shares during the same period.